This study examined the effects of extremely-high-frequency therapy as administered via a 1 apparatus (7.1 mm wavelength) on tuberculosis patients. Results showed a 25-percent improvement in patients receiving the therapy as a pathogenic treatment. A 72-percent improvement rate was seen among patients who received the therapy as treatment for concurrent diseases.
T.V. Kalinina V.D. Churaev, Expense with the Use of the EHF-Therapy at Ryasan’ Regional Clinical TB Dispensary, Millimetrovie Volni v Biologii i Meditcine, (4), 1994, p. 52-53.
